Crossmark

Circulating tumor cells as marker of poor prognosis in metastatic lung cancer: a pilot study

Crossref DOI link: https://doi.org/10.1186/s41241-018-0059-7

Published Online: 2018-03-12

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Diaz, Mônica Taiane de Macêdo

Abdallah, Emne Ali

Tariki, Milena Shizue

Braun, Alexcia Camila

Dettino, Aldo Lourenço Abbade

Nicolau, Ulisses Ribaldo

Alves, Vanessa da Silva

Chinen, Ludmilla Thomé Domingos http://orcid.org/0000-0001-7890-8420
Funding

Funding for this research was provided by:

FAPESP (2012/01273-8)

CNPq (135530/2016-4)
License Information

Text and Data Mining valid from 2018-03-12
More Information

Article History

Received: 10 October 2017

Accepted: 5 February 2018

First Online: 12 March 2018

Ethics approval and consent to participate

: All procedures were performed according to the ethical standards of the institutional research committee (A.C. Camargo Cancer Center; reference number: 1367/10).

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.